期刊文献+
共找到19篇文章
< 1 >
每页显示 20 50 100
粒-单细胞集落刺激因子在血液病治疗中的应用 被引量:1
1
作者 崔钊 牛亚明 +1 位作者 于少军 李同义 《医学综述》 1996年第1期12-13,共2页
粒-单细胞集落刺激因子(下简称GM-CSF)主要是由单核、巨噬细胞,血管内皮细胞,纤维母细胞.骨髓间质细胞及粒细胞产生的一种糖蛋白激素.对血液系统有广泛的作用.主要作用于骨髓的早期多能于细胞,促进粒细胞的生长发育,而且对巨噬细胞的生... 粒-单细胞集落刺激因子(下简称GM-CSF)主要是由单核、巨噬细胞,血管内皮细胞,纤维母细胞.骨髓间质细胞及粒细胞产生的一种糖蛋白激素.对血液系统有广泛的作用.主要作用于骨髓的早期多能于细胞,促进粒细胞的生长发育,而且对巨噬细胞的生长是必须的,因而对于血液病的研究与治疗有密切关系.下面就其生理功能.临床应用,有争议的问题及副作用综述如下. 展开更多
关键词 血液病 药物疗法 粒-单细胞 集落刺激因子
下载PDF
粒-单细胞集落刺激因子的研究进展
2
作者 崔钊 牛亚明 《国外医学(内科学分册)》 1996年第6期256-258,共3页
本文综述了近年来对粒-单细胞集落刺激因子的研究进展,主要阐述了其生理功能、临床应用及有争议的问题。
关键词 粒-单细胞 集落刺激因子 白血病 骨髓移植
下载PDF
治疗急性粒-单细胞性白血病4例报道
3
作者 甄冲 《上海中医药杂志》 北大核心 2001年第1期23-24,共2页
吴翰香教授治疗急性粒 -单细胞性白血病 4例 ,报道基本治疗过程。其中有 2例因化疗过量 ,导致仅存活 3年余 ,另 2例化疗适可而止 ,坚持长期中药治疗 ,已分别存活 8年、4年以上。说明化疗过量之危害与弊端 ,中药结合适度化疗疗效较好。
关键词 急性粒-单细胞性白血病 化疗 中医中药 疗效
下载PDF
慢性粒-核单细胞白血病合并其他肿瘤6例 被引量:1
4
作者 吴萍 翁建宇 杜欣 《临床内科杂志》 CAS 2013年第5期340-341,共2页
目的 探讨慢性粒-单核细胞白血病合并其他肿瘤的临床特点、疗效及预后,以减少漏诊.方法 回顾性分析6例慢性粒-单核细胞白血病合并其他肿瘤患者的临床资料与实验室检查结果.结果 在确诊为慢性粒-单核细胞白血病的37例患者中,同时合并其... 目的 探讨慢性粒-单核细胞白血病合并其他肿瘤的临床特点、疗效及预后,以减少漏诊.方法 回顾性分析6例慢性粒-单核细胞白血病合并其他肿瘤患者的临床资料与实验室检查结果.结果 在确诊为慢性粒-单核细胞白血病的37例患者中,同时合并其他肿瘤6例,占16.2% (6/37),合并其他肿瘤的患者对化疗及移植治疗效果欠佳.结论 慢性粒-单细胞白血病患者在就诊时需全面检查,早期发现合并实体肿瘤,以减少误诊漏诊. 展开更多
关键词 慢性粒-单细胞白血病 其他肿瘤
下载PDF
慢性粒-单细胞白血病染色体异常一例
5
作者 温莉娟 盂昭彦 +2 位作者 侯美仙 刘利明 张玫 《中华医学遗传学杂志》 CAS CSCD 北大核心 2006年第6期613-613,共1页
关键词 粒-单细胞 染色体异常 白血病 细胞碱性磷酸酶 慢性 单核细胞 活动后心悸 实验室检查
原文传递
孕妇血中GM-CSF、IL-2和IL-6的含量和意义 被引量:1
6
作者 甘柏柳 杨萍 +4 位作者 徐杏美 张新华 朱凌 蔡利群 周天红 《中国妇幼保健》 CAS 2002年第5期286-287,共2页
目的 :探讨 GM- CSF、IL- 2和 IL- 6在孕妇血中的含量及临床意义。方法 :采用 EL ISA法检测健康妇女和孕妇血中 GM- CSF、IL- 2和 IL- 6含量进行对比。结果 :孕妇血中 3种因子含量高于健康妇女 ,差异有显著意义(P<0 .0 1)。结论 :孕... 目的 :探讨 GM- CSF、IL- 2和 IL- 6在孕妇血中的含量及临床意义。方法 :采用 EL ISA法检测健康妇女和孕妇血中 GM- CSF、IL- 2和 IL- 6含量进行对比。结果 :孕妇血中 3种因子含量高于健康妇女 ,差异有显著意义(P<0 .0 1)。结论 :孕妇血中 GM- CSF、 IL - 2和 IL - 6含量显著增加 。 展开更多
关键词 孕妇 血清学检验 粒-单细胞集落刺激因子 细胞介素-2 细胞介素-6 胚胎发育
下载PDF
Platinum Nanoparticle-based Collision Electrochemistry for Rapid Detection of Breast Cancer MCF-7 Cells
7
作者 Fu-Xing Qin Ming-Ke Li +4 位作者 Hui-Long Zhou Wei Wen Xiu-Hua Zhang Sheng-Fu Wang Zhen Wu 《电化学(中英文)》 CAS 北大核心 2024年第10期19-27,共9页
Cancer metastasis is the leading cause of death in cancer patients worldwide and one of the major challenges in treating cancer.Circulating tumor cells(CTCs)play a pivotal role in cancer metastasis.However,the content... Cancer metastasis is the leading cause of death in cancer patients worldwide and one of the major challenges in treating cancer.Circulating tumor cells(CTCs)play a pivotal role in cancer metastasis.However,the content of CTCs in peripheral blood is minimal,so the detection of CTCs in real samples is extremely challenging.Therefore,efficient enrichment and early detection of CTCs are essential to achieve timely diagnosis of diseases.In this work,we constructed an innovative and sensitive single-nanoparticle collision electrochemistry(SNCE)biosensor for the detection of MCF-7 cells(human breast cancer cells)by immunomagnetic separation technique and liposome signal amplification strategy.Liposomes embedded with platinum nanoparticles(Pt NPs)were used as signal probes,and homemade gold ultramicroelectrodes(Au UME)were used as the working electrodes.The effective collision between Pt NPs and UME would produce distinguishable step-type current.MCF-7 cells were accurately quantified according to the relationship between cell concentration and collision frequency(the number of step-type currents generated per unit time),realizing highly sensitive and specific detection of MCF-7 cells.The SNCE biosensor has a linear range of 10 cells·mL^(-1)to 10^(5) cells·mL^(-1)with a detection limit as low as 5 cells·mL^(-1).In addition,the successful detection of MCF-7 cells in complex samples showed that the SNCE biosensors have great potential for patient sample detection. 展开更多
关键词 Circulating tumor cells Single-nanoparticle collision electrochemistry Immunomagnetic separation LIPOSOME Platinum nanoparticles
下载PDF
GM-CSF受体在白血病中的表达及意义
8
作者 和虹 杨丽萍 +1 位作者 钱林生 贾海蓉 《大理医学院学报》 2001年第1期6-7,共2页
目的:了解 GM-CSF受体 (CD116)在急性白血病中的表达及其临床意义。方法:对 114例急性白血病患者进行免疫表型、细胞遗传学分析。结果: CD116在 ALL中无阳性表达,而在 AML中表达率为 42. 4%, CD116在 FAB各亚型间的出现频率存在... 目的:了解 GM-CSF受体 (CD116)在急性白血病中的表达及其临床意义。方法:对 114例急性白血病患者进行免疫表型、细胞遗传学分析。结果: CD116在 ALL中无阳性表达,而在 AML中表达率为 42. 4%, CD116在 FAB各亚型间的出现频率存在明显差异, M5中阳性率最高为 83. 3%, M4为 40%, M3、 M2分别为 27. 2%、 15. 0%。 CD116+ AML中未见特异性染色体异常,但 M5患者 2例出现+ 8异常,均在 CD116+组。结论: CD116主要表达在髓系白血病,且与具有单核细胞特征的白血病相关, CD116、 CD4联合染色体+ 8有利于 M5亚型的诊断。 展开更多
关键词 粒-单细胞集落刺激因子受体 白血病 基因表达 免疫学分型
下载PDF
复方甲亢片对Graves病大鼠血清GM-CSF和溶菌酶的影响
9
作者 周亚娜 向楠 《湖北中医杂志》 2008年第5期5-6,共2页
目的:研究复方甲亢片对Graves病(GD)大鼠血清GM-CSF和溶菌酶的影响。方法:小肠结肠炎耶尔森氏菌种尾静脉免疫注射建立Graves病大鼠模型。随机分为正常组、模型组、复方甲亢片组、中药组、他巴唑组。灌胃治疗30天后,取外周血,ELISA法测... 目的:研究复方甲亢片对Graves病(GD)大鼠血清GM-CSF和溶菌酶的影响。方法:小肠结肠炎耶尔森氏菌种尾静脉免疫注射建立Graves病大鼠模型。随机分为正常组、模型组、复方甲亢片组、中药组、他巴唑组。灌胃治疗30天后,取外周血,ELISA法测定血清GM-CSF,比浊法测定血清溶菌酶。结果:各组大鼠之间血清GM-CSF水平无显著性差异(P>0.05)。复方甲亢片组以及中药组大鼠血清溶菌酶水平与他巴唑组比较有显著性差异(P<0.01),他巴唑组大鼠血清溶菌酶较模型组增高,有显著性差异(P<0.01)。结论:复方甲亢片中的中药组分对GD大鼠白细胞的保护作用可能是通过防止白细胞的破坏实现的。 展开更多
关键词 GRAVES病 复方甲亢片 粒-单细胞集落刺激因子 溶菌酶
下载PDF
急性粒—单细胞白血病并发Sweet综合征1例 被引量:1
10
作者 刘洪涛 吴晓雄 李红华 《白血病.淋巴瘤》 CAS 2002年第4期250-250,共1页
关键词 并发症 急性粒-单细胞白血病 SWEET综合征
原文传递
Predictive factors of clinical response in steroid-refractory ulcerative colitis treated with granulocyte-monocyte apheresis 被引量:2
11
作者 Valeria D'Ovidio Donatella Meo +3 位作者 Angelo Viscido Giampaolo Bresci Piero Vernia Renzo Caprilli 《World Journal of Gastroenterology》 SCIE CAS CSCD 2011年第14期1831-1835,共5页
AIM:To identify factors predicting the clinical response of ulcerative colitis patients to granulocyte-monocyte apheresis (GMA). METHODS:Sixty-nine ulcerative colitis patients (39 F,30 M) dependent upon/refractory to ... AIM:To identify factors predicting the clinical response of ulcerative colitis patients to granulocyte-monocyte apheresis (GMA). METHODS:Sixty-nine ulcerative colitis patients (39 F,30 M) dependent upon/refractory to steroids were treated with GMA. Steroid dependency,clinical activity index (CAI),C reactive protein (CRP) level,erythrocyte sedimentation rate (ESR),values at baseline,use of immunosuppressant,duration of disease,and age and extent of disease were considered for statistical analysis as predictive factors of clinical response. Univariate and multivariate logistic regression models were used. RESULTS:In the univariate analysis,CAI (P = 0.039) and ESR (P = 0.017) levels at baseline were singled out as predictive of clinical remission. In the multivariate analysis steroid dependency [Odds ratio (OR) = 0.390,95% Confidence interval (CI):0.176-0.865,Wald 5.361,P = 0.0160] and low CAI levels at baseline (4 < CAI <7) (OR = 0.770,95% CI:0.425-1.394,Wald 3.747,P = 0.028) proved to be effective as factors predicting clinical response. CONCLUSION:GMA may be a valid therapeutic option for steroid-dependent ulcerative colitis patients with mild-moderate disease and its clinical efficacy seems to persist for 12 mo. 展开更多
关键词 Granulocyte-monocyte apheresis Ulcerative colitis Steroid therapy Long-term follow-up Predictive factors
下载PDF
The Influence of IFN-α on Blood Plasmacytoid Dendritic Cell in Chronic Myeloid Leukaemia
12
作者 Chongyang Wu Liansheng Zhang Ye Chai Feixue Song Pengyun Zeng Lijuan Li Lingling Yue Bin Xiong 《Chinese Journal of Clinical Oncology》 CSCD 2009年第2期113-116,共4页
OBJECTIVE To study the mechanism of IFN on CML.METHODS Samples of 15 CML patients and 10 healthy controlswere studied. The flow cytometry was performed to identifycirculating pDCs. The concentration of IFN-α in serum... OBJECTIVE To study the mechanism of IFN on CML.METHODS Samples of 15 CML patients and 10 healthy controlswere studied. The flow cytometry was performed to identifycirculating pDCs. The concentration of IFN-α in serum and that inthe supernatant of peripheral blood mononuclear cells (PBMCs)cultured after stimulation with CpG ODN2216 were examinedboth in CML patients and in the healthy controlsRESULTS There was significant reduction in the numberof circulating pDCs, serum concentration of IFN-α and thecapacity of IFN-α producing PBMCs in CML patients comparedwith those in healthy control individuals (P < 0.001). After theactive treatment with IFN-α and hydroxyurea, the quantity andfunction of pDCs were increased in stabilized patients, especiallythe function of pDCs in 2 patients achieving major cytogeneticresponse (MCR). The proportion and function of pDCs and theserum levels of IFN were inversely correlated with both WBC andage of the patients with CML, and positively correlated with thestate of the illness.CONCLUSION CML patients had a reduced number anddysfunction of circulating pDCs. The active treatment with IFN inCML patients may be related to the restoration of pDCs. 展开更多
关键词 chronic myeloid leukaemia plasmacytoid dendritic cell IFN-α.
下载PDF
儿童急性髓系白血病(M4/M5亚型)系统治疗的临床效果及预后因素分析 被引量:2
13
作者 白峰岩 王学博 +2 位作者 赵方 郭婉贞 陈志鑫 《实用癌症杂志》 2022年第1期154-156,共3页
目的分析儿童急性髓系白血病(M4/M5亚型)系统治疗的临床效果及预后因素。方法回顾性分析AML患儿50例临床资料,其中M4患儿27例,M5患儿23例;入选患儿均进行系统治疗,观察临床效果。对患儿进行随访,记录患儿预后情况,并分析影响预后的危险... 目的分析儿童急性髓系白血病(M4/M5亚型)系统治疗的临床效果及预后因素。方法回顾性分析AML患儿50例临床资料,其中M4患儿27例,M5患儿23例;入选患儿均进行系统治疗,观察临床效果。对患儿进行随访,记录患儿预后情况,并分析影响预后的危险因素。结果50例AML患儿治疗8 d后,总有效率为80.00%(40/50);经28 d治疗后,总有效率为84.00%(42/50)。至随访结束,50例AML患儿预后较好24例,占比为48.00%。预后良好组中有髓外浸润、强化疗疗程<6次、8 d治疗未缓解占比均低于预后不良组,差异有统计学意义(P<0.05);Logistic回归分析:有髓外浸润、强化疗疗程<6次、8 d治疗未缓解是M4/M5亚型患儿预后不良的独立危险因素(P<0.05且OR≥1)。结论急性髓系白血病M4/M5亚型患儿预后普遍较差,髓外浸润、强化疗疗程不足、初期治疗效果是预后不良的主要影响因素。临床对伴有高危因素的患儿应予以高度重视,选择针对性治疗方案。 展开更多
关键词 急性髓系白血病 儿童 急性粒-单细胞白血病 急性单核细胞白血病 预后因素
下载PDF
Regulatory T cells in patients with inflammatory bowel diseases treated with adacolumn granulocytapheresis 被引量:7
14
作者 Emilio Cuadrado Marta Alonso +2 位作者 Maria Dolores de Juan Pilar Echaniz Juan Ignacio Arenas 《World Journal of Gastroenterology》 SCIE CAS CSCD 2008年第10期1521-1527,共7页
AIM: To investigate if the clinical efficacy of granulocytes and monocytes by adsorption (GMA) is associated with an increased frequency of peripheral regulatory T cells (Tregs), as these cells have proven to be succe... AIM: To investigate if the clinical efficacy of granulocytes and monocytes by adsorption (GMA) is associated with an increased frequency of peripheral regulatory T cells (Tregs), as these cells have proven to be successful in suppressing inflammatory bowel disease (IBD) in animal models. METHODS: We report four cases of corticosteroid- dependent ulcerative colitis (UC) and two Crohn’s disease (CD) cases with severe cutaneous lesions who received GMA therapy. The frequency of CD4+ CD25high (Tregs) in peripheral blood was analyzed by flow cytometry and the expression of FoxP3 and TGF beta in purified CD4+ T cells was determined by real time PCR prior to and one month after the last apheresis session, and at the time of endoscopic and clinical assessing. RESULTS: Increased expression of Fox P3 mRNA was found in all five patients who responded to cytapheresis with remission of clinical symptoms, mucosal inflammation and cutaneous lesions, and an increased frequency of circulating Tregs was found in four patients. These changes were not observed in the patient with UC who did no respond to GMA. Variations in TGF-β (mRNA) did not parallel that of FoxP3 mRNA. CONCLUSION: The clinical efficacy of GMA on IBD and related extra intestinal manifestations was associated with an expansion of circulating CD4+ CD25+ Tregs and higher expression of FoxP3 in CD4+ T cells. Accordingly, an elevated CD4+ CD25+ FoxP3 may be a valuable index of remission in patients with IBD and other chronic relapsing-remitting inflammatory conditions during treatment with GMA. 展开更多
关键词 Adsorptive leukocytapheresis Regulatory T cells Inflammatory bowel diseases Adacolumn Granulocyte-monocyte adsortive apheresis
下载PDF
Study on neoplasia of hydatidiform mole by detecting telomerase reverse transcriptase mRNA expression in peripheral blood mononuclear cells
15
作者 Bao Lijun Xu Jing +3 位作者 Yang Shangwu Li Fen Zou Yuliang Huang Hui 《Journal of Medical Colleges of PLA(China)》 CAS 2010年第2期84-90,共7页
By setting up a real-time fluorescent quantitative RT-PCR assay to detect human telomerase reverse transcriptase (hTERT) mRNA in hydatidiform mole in peripheral blood mononuclear cells, to analyze the correlation be... By setting up a real-time fluorescent quantitative RT-PCR assay to detect human telomerase reverse transcriptase (hTERT) mRNA in hydatidiform mole in peripheral blood mononuclear cells, to analyze the correlation between the expression level of hTERT mRNA and the prognosis of hydatidiform mole, and to evaluate the clinic value of quantitative determination of hTERT mRNA in the diagnosis of hydatidiform mole. Methods: A real-time fluorescent quantitative RT-PCR (FQ RT-PCR) assay based on TaqMan fluorescence methodology and the Light-Cycler system was used to quantify the full range of hTERT mRNA copy numbers in 30 samples of hydatidiform mole and the neoplasia of hydatidiform mole. The normalized hTERT (NhTERT) was standardized by quantifying the number of GAPDH transcripts as internal control and expressed as 100x (hTERT/GAPDH) ratio. Based on the prognosis of the hydatidiform mole, the patients were divided into two groups: the experimental group and the control group, to compare the telomerase reverse transcriptase mRNA expression in peripheral blood mononuclear cells. Results: hTERT mRNA was both expressed in the peripheral blood mononuclear cells and pathological tissues in the mole experimental group and the control group. In the mole experimental group, the values were 6.31±0.32 and 6.24±0.44, respectively, and there was no significant difference between them (P〉0.05). But in the control group the values were 1.21±0.65 and 1.40±0.61, respectively, and there was no significant difference between them (P〉0.05) The values in experimental group was significantly higher than those in the control group (P〈0.01). Conclusion: Quantitative determination of hTERT mRNA by FQ RT-PCR is a rapid and sensitive method, hTERT in peripheral blood mononuclear cells may have potential use as a biomarker for the early detection of the prognosis of the hydatidiform mole. 展开更多
关键词 FQ RT-PCR Hydatidiform mole TELOMERASE Reverse transcriptase
下载PDF
Identification of the Tumor Factor of Abnormal Cancer Methylation Enzymes as the Catalytic Subunit of Telomerase
16
作者 Ming C. LIA U Pei-zhuang ZHU George C. Y CHIOU 《Clinical oncology and cancer researeh》 CAS CSCD 2010年第2期86-96,共11页
OBJECTIVE The objective was to study the relationship between the tumor factor of cancer MATLT and the catalytic subunit of telomerase. The function of telomerase in the blockade of cell differentiation and in the pro... OBJECTIVE The objective was to study the relationship between the tumor factor of cancer MATLT and the catalytic subunit of telomerase. The function of telomerase in the blockade of cell differentiation and in the protection of DNA MT resembles closely the function of the tumor factor of cancer MATKw. Because of this close similarity we made an attempt to examine the possibility that the tumor factor of MATKT might be the catalytic subunit of telomerase. METHODS We used purified MAT isozymes, telomerase antibody, immunoprecipitation, and a selective inhibitor of the tumor factor of MATLT from urine to study the relationship between the tumor factor of MATLT and telomerase. RESULTS We were able to show that the tumor MATcw, but not the liver MATL, was selectively inhibited by the telomerase antibody, and the tumor MATLT, but not the liver MATL, was preferentially immunoprecipitated with the telomerase antibody. The catalytic subunit of telomerase was detectable in the tumor MATLT preparation by immunoblotting, but was undetectable in the liver MATc preparation and the tumor MATc preparation stripped off of the tumor factor. In addition, PP-0.39, which is an effective differentiation inducer purified from urine previously found to selectively antagonize the tumor factor of MATLT, was found in this study to be a potent inhibitor of telomerase. The inhibition of telomerase by PP-0.39 was far more sensitive than the elimination of the tumor factor from MATLT. CONCLUSION All results are consistent with the hypothesis that the tumor factor of MATLT is the catalytic subunit of telomerase. Thus, the blockade of cell differentiation by telomerase is mediated through its interaction with MAT to affect methylation enzymes, so that hypomethylation of nucleic acids necessary for the cell to undergo differentiation cannot take place. 展开更多
关键词 TELOMERASE tumor factor of MATLT methylation enzymes differentiation.
下载PDF
Increased Activity of the Human Telomerase Catalytic Subunit Promoter by the VEGF Enhancer in Human Cancer Cells
17
作者 Huwei1 Mengxingyu +2 位作者 Tianyuhua Zangyujing Hurui 《International Journal of Technology Management》 2014年第9期140-142,共3页
We attempted to improve the activity of hTERT promoter by fusing the vascular endothelial growth factor (VEGF) enhancer. To determine the potential as cancer specific promoters, we measured the reporter gene transfe... We attempted to improve the activity of hTERT promoter by fusing the vascular endothelial growth factor (VEGF) enhancer. To determine the potential as cancer specific promoters, we measured the reporter gene transfection assay driven by the hTERT promoter and the VEGF enhancer in human cancer cells. We found that the hTERT promoter containing VEGF enhancer conferred strong expression of the reporter gene only in different cancer cell lines but not in normal human cells. Retrovirus vector expressing HSV-TK controlled by the hTERT promoter and the VEGF enhancer was constructed. A549 cells infected with LN-enh-hT-TK was significantly suppressed and induced to apoptosis more than those infected with LN-hT-TK. The apoptosis ratio ofA549 cell infected with two kinds of retrovirus cell with GCV in lower concentration is 20.94% and 50.7%. It suggested that there is significant differentiation between the assay groups. Our results demonstrated the possible application of hTERT promoter and the VEGF enhancer in targeted cancer gene therapy. 展开更多
关键词 hTERT promoter VEGF enhancer RETROVIRUS targeted cancer gene therapy
下载PDF
Special topic for “single-molecule, single-particle and single-cell bioimaging” 被引量:1
18
作者 Chunhai Fan Xiaohong Fang 《Science China Chemistry》 SCIE EI CAS CSCD 2017年第10期1265-1266,共2页
Revealing the behavior of single molecules in single live cells provides a fundamental approach to understand cellular organization and dynamics.With the rapid merging of biotechnology and nanotechnology in recent yea... Revealing the behavior of single molecules in single live cells provides a fundamental approach to understand cellular organization and dynamics.With the rapid merging of biotechnology and nanotechnology in recent years,single plasmonic nanoparticle sensors have endowed a new dimension to the imaging scale given their comparable size to biomolecules such as nucleic acids or antibodies. 展开更多
关键词 nanotechnology endowed biotechnology merging comparable technological nucleic overview contributions advances
原文传递
儿童急性髓系白血病(M4/M5亚型)临床疗效及预后因素分析 被引量:8
19
作者 陈凯 蒋慧 +6 位作者 陆正华 邵静波 杨静薇 李红 张娜 朱嘉莳 邹冰 《中华实用儿科临床杂志》 CSCD 北大核心 2018年第3期186-190,共5页
目的探讨儿童急性髓系白血病M4/M5亚型的临床疗效及预后相关因素。方法回顾性分析2009年1月至2014年12月上海市儿童医院收治的M4/M5亚型患儿临床资料,进行远期疗效、预后及复发因素分析。结果收集符合诊断的46例患儿临床资料,其中3... 目的探讨儿童急性髓系白血病M4/M5亚型的临床疗效及预后相关因素。方法回顾性分析2009年1月至2014年12月上海市儿童医院收治的M4/M5亚型患儿临床资料,进行远期疗效、预后及复发因素分析。结果收集符合诊断的46例患儿临床资料,其中38例接受2个疗程以上治疗并纳入统计,其中男22例,女16例;M419例,M519例;中位年龄5岁。5年总体生存(OS)率为(57.7±9.3)%,5年无事件生存(EFS)率为(47.2±8.9)%,M45年EFS率为(52.4±12.7)%,M55年EFS率为(45.4±11.9)%。按国际危险度分层比较:预后良好、预后中等和预后不良组5年EFS率分别为(77.2±12.4)%、(49.5±14.9)%和(25.0±19.8)%,差异有统计学意义(χ2=6.305,P=0.043)。单因素分析显示髓外浸润、染色体核型、诱导治疗第8天骨髓反应评估、治疗疗程为影响预后的因素(χ2=4.828、10.178、5.382、4.771,P=0.028、0.017、0.020、0.029);多因素分析显示髓外浸润(HR=5.323,95%CI:1.620-17.490,P=0.006)、〈6个疗程治疗(HR=6.186,95%C1:1.726~22.176,P=0.005)是影响生存的独立危险因素。结论1.儿童髓系白血病M4/M5亚型强化疗和足疗程是提高总体疗效的关键。2.髓外浸润是影响生存和导致复发的主要危险因素。3.初始评估有高危因素伴预后不良患儿建议尽早行造血干细胞移植。 展开更多
关键词 急性粒-单细胞白血病 急性单核细胞白血病 急性髓系白血病 化疗 预后
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部